NI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Not a good buy right now for an impatient trader: near-term signals skew slightly bearish (MACD rolling over; pattern study implies ~-2% to -3% downside over the next day/week).", "The setup is better for a post-earnings decision: QDEC 2025 earnings are on 2026-02-11 (pre-market), which is a near-term catalyst that can easily override the current mild uptrend in moving averages.", "Medium-term backdrop is constructive (bullish MA structure, mostly positive analyst stance, and improving recent quarter fundamentals), but timing today is not attractive without an Intellectia buy signal."]
["Trend/Momentum: SMA_5 > SMA_20 > SMA_200 suggests an underlying bullish trend, but momentum is weakening (MACD histogram -0.0176 below zero and negatively expanding).", "RSI(6) = 47.6 is neutral, consistent with a pause/transition rather than a clean continuation entry.", "Key levels: Pivot 43.982 is slightly above the current 43.84 (trading just under pivot). Immediate support S1 43.202 then S2 42.721; resistance R1 44.761 then R2 45.242.", "Short-term probability model (pattern-based): 70% chance of ~-3.12% next day and ~-2.3% next week, but +9.43% next month\u2014supports a 'wait for dip/confirmation' approach rather than chasing now.", "Intellectia Proprietary Trading Signals: - AI Stock Picker: No signal on given stock today. - SwingMax: No signal on given stock recently."]
and Buy/Outperform-style ratings.", "Earnings catalyst on 2026-02-11 (pre-market): potential upside surprise could re-rate the stock quickly if results/forward commentary are strong.", "Recent operating momentum (2025/Q
shows strong YoY revenue and income growth, supportive for a regulated utility narrative."]
["Near-term technical momentum is soft (MACD deterioration) and price is slightly below pivot, increasing the odds of a quick retest of 43.20/42.72 supports.", "Pre-earnings event risk in less than a week: an impatient entry now risks getting caught in an earnings-driven gap without confirmation.", "No recent newsflow tailwinds in the past week; absent a catalyst, the stock may drift/mean-revert short term."]
["Latest reported quarter: 2025/Q3.", "Revenue: $1.273B, +18.28% YoY (strong top-line acceleration).", "Net income: $94.4M, +10.41% YoY (profitability improving).", "EPS: $0.20, +5.26% YoY (steady, but growth slower than revenue).", "Gross margin: 60.69%, +1.91% YoY (margin expansion supports earnings quality)."]
["Recent trend: price targets have generally moved up (BMO to $49 from $47; UBS to $48 from $45), with one modest trim (Barclays to $45 from $46) while maintaining an Overweight stance.", "Street view (pros): supportive regulatory/contract-related developments referenced by BMO; multiple firms reiterate bullish ratings; targets imply upside from 43.84 (roughly ~3% to ~12%).", "Street view (cons): mixed target adjustments (Barclays small cut) suggests upside is viewed as more incremental; near-term returns may rely on execution and upcoming earnings commentary.", "Flows/holders: hedge fund and insider activity described as neutral; no recent congress trading data available and no politician/influential-figure trades were provided."]
